Heartland Advisors’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-159,351
| Closed | -$3.17M | – | 181 |
|
2024
Q1 | $3.17M | Sell |
159,351
-231,740
| -59% | -$4.61M | 0.17% | 151 |
|
2023
Q4 | $9.44M | Sell |
391,091
-182,004
| -32% | -$4.39M | 0.49% | 85 |
|
2023
Q3 | $12.8M | Sell |
573,095
-1,017
| -0.2% | -$22.7K | 0.72% | 45 |
|
2023
Q2 | $14.7M | Buy |
574,112
+78,806
| +16% | +$2.01M | 0.84% | 33 |
|
2023
Q1 | $14.7M | Buy |
495,306
+61,930
| +14% | +$1.84M | 0.91% | 27 |
|
2022
Q4 | $11.7M | Sell |
433,376
-28,338
| -6% | -$767K | 0.74% | 43 |
|
2022
Q3 | $10.1M | Buy |
461,714
+66,573
| +17% | +$1.45M | 0.75% | 44 |
|
2022
Q2 | $10.8M | Buy |
395,141
+46,287
| +13% | +$1.27M | 0.75% | 45 |
|
2022
Q1 | $11.7M | Buy |
348,854
+417
| +0.1% | +$14K | 0.72% | 44 |
|
2021
Q4 | $12.1M | Buy |
348,437
+41,021
| +13% | +$1.42M | 0.71% | 43 |
|
2021
Q3 | $9.59M | Buy |
307,416
+66,692
| +28% | +$2.08M | 0.58% | 65 |
|
2021
Q2 | $8.76M | Buy |
240,724
+15,000
| +7% | +$546K | 0.51% | 78 |
|
2021
Q1 | $9.87M | Sell |
225,724
-5,809
| -3% | -$254K | 0.62% | 53 |
|
2020
Q4 | $10.6M | Sell |
231,533
-25,951
| -10% | -$1.19M | 0.76% | 39 |
|
2020
Q3 | $8.55M | Hold |
257,484
| – | – | 0.74% | 45 |
|
2020
Q2 | $7.57M | Buy |
257,484
+21,040
| +9% | +$618K | 0.67% | 62 |
|
2020
Q1 | $6.37M | Buy |
236,444
+184,504
| +355% | +$4.97M | 0.68% | 56 |
|
2019
Q4 | $1.75M | Sell |
51,940
-28,762
| -36% | -$969K | 0.13% | 162 |
|
2019
Q3 | $3.02M | Sell |
80,702
-81,220
| -50% | -$3.04M | 0.23% | 146 |
|
2019
Q2 | $7.06M | Buy |
161,922
+53,211
| +49% | +$2.32M | 0.52% | 91 |
|
2019
Q1 | $4.64M | Buy |
+108,711
| New | +$4.64M | 0.34% | 127 |
|